Optical coherence tomography in neurological diseases:
Optical coherence tomography (OCT) provides tissue morphology imagery at much higher resolution than other imaging modalities such as MRI or ultrasound, and the machines are comparatively cheaper. It is an easy technique to perform; is non-ionizing, and therefore safe. These benefits are driving a r...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge
Cambridge University Press
2015
|
| Schlagworte: | |
| Online-Zugang: | BSB01 FHN01 Volltext |
| Zusammenfassung: | Optical coherence tomography (OCT) provides tissue morphology imagery at much higher resolution than other imaging modalities such as MRI or ultrasound, and the machines are comparatively cheaper. It is an easy technique to perform; is non-ionizing, and therefore safe. These benefits are driving a rapid transformation of OCT, from its principal application as a research tool, into an extension of the 'neurological examination' in routine office practice. Originally used in assessing the severity of tissue damage and prognosis of multiple sclerosis and various neuro-ophthalmic conditions, OCT is increasingly used in other neurological disorders such as Parkinson's disease, ALS, and Alzheimer's disease. This book is the first comprehensive review of the use of OCT in neurological diseases. The coverage includes a description of the technique and its utilization in a variety of neurologic conditions. Essential reading for neurologists, neuro-ophthalmologists, and neuroradiologists wanting an introductory account of the clinical applications of OCT. |
| Beschreibung: | Title from publisher's bibliographic system (viewed on 05 Oct 2015) |
| Beschreibung: | 1 online resource (ix, 224 pages) |
| ISBN: | 9781139649506 |
| DOI: | 10.1017/CBO9781139649506 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043940445 | ||
| 003 | DE-604 | ||
| 005 | 20170505 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 161206s2015 |||| o||u| ||||||eng d | ||
| 020 | |a 9781139649506 |c Online |9 978-1-139-64950-6 | ||
| 024 | 7 | |a 10.1017/CBO9781139649506 |2 doi | |
| 035 | |a (ZDB-20-CBO)CR9781139649506 | ||
| 035 | |a (OCoLC)967678786 | ||
| 035 | |a (DE-599)BVBBV043940445 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-92 | ||
| 082 | 0 | |a 616.8/04757 |2 23 | |
| 245 | 1 | 0 | |a Optical coherence tomography in neurological diseases |c edited by Peter A. Calabresi, MD, FAAN, FANA, Professor of Neurology, Director of the Richard T. Johnson Division of Neuroimmulogy and Neuroinfectious Diseases, and Director of the Johns Hopkins Multiple Sclerosis Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA, Laura J. Balcer, MD, MSCE, FANA, Professor of Neurology, Population Health and Opthalmalogy, Vice Chair, Department of Neurology, NYU School of Medicine, NY, USA, Elliot M. Frohman, MD, PhD, FAAN, Professor of Neurology and Opthalmology, Distinguished Teaching Professor, Kenney-Marie Dixon Pickens, Distinguished Professor of MS Research, Irene Wadel & Robert Artha Distinguished Chair in Neurology, Director, Multiple Sclerosis and Neuroimmunology Program and Clinical Center for Multiple Sclerosis, University of Texas Southwestern School of Medicine |
| 264 | 1 | |a Cambridge |b Cambridge University Press |c 2015 | |
| 300 | |a 1 online resource (ix, 224 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Title from publisher's bibliographic system (viewed on 05 Oct 2015) | ||
| 505 | 8 | |a Machine generated contents note: Preface; 1. Introduction to optical coherence tomography in neurological diseases Peter A. Calabresi, Laura J. Balcer and Elliot M. Frohman; 2. Basic principles of optical coherence tomography Sven Schippling; 3. Anatomy of the anterior visual pathway Devin D. Mackay, Stephen L. Galetta and Sashank Prasad; 4. Optical coherence tomography in acute optic neuritis Andrew P.D. Henderson, S. Anand Trip and David H. Miller; 5. Optical coherence tomography and visual outcomes in acute optic neuritis Fiona Costello; 6. Optical coherence tomography and low contrast acuity Shin C. Beh and Laura J. Balcer; 7. Optical coherence tomography and electrophysiology of the visual pathway A. Klistorner, C.L. Fraser, C. Yiannikas and S.L. Graham; 8. Optical coherence tomography and electrophysiology of the optic nerve head Shin C. Beh, Zane Schnurman, Darrel Conger, Amy Conger, Benjamin M. Greenberg, Elliot M. Frohman and Teresa C. Frohman; 9. | |
| 505 | 8 | |a Meta-analysis of optical coherence tomography in multiple sclerosis Axel Petzold; 10. Optical coherence tomography and brain MRI in multiple sclerosis Shiv Saidha and Peter A. Calabresi; 11. Optical coherence tomography in neurodegenerative diseases Friedemann Paul and Alexander Ulrich Brandt; 12. Optical coherence tomography pathologies to know about in clinical practice Scott Newsome and John N. Ratchford; 13. Optical coherence tomography and retinal segmentation in neurological diseases Elias S. Sotirchos and Shiv Saidha; 14. Optical coherence tomography and retinal pathology in neurologic diseases Ari J. Green; 15. Retinal inflammation in MS revealed by optical coherence tomography and ophthalmoscopy Elena H. Martinez-Lapiscina, Bernardo Sanchez-Dalmau and Pablo Villoslada; 16. Optical coherence tomography and optic nerve MRI in demyelinating diseases Robert T. Naismith; 17. Optical coherence tomography in neurologic clinical trials Robert A. Bermel and Peter K. Kaiser; 18. | |
| 505 | 8 | |a Optical coherence tomography in multi-center setting: quality control issues Axel Petzold, Laura J. Balcer, Peter A. Calabresi, Fiona Costello, Elliot M. Frohman, Ari J. Green, Sasha Klistorner, Friedemann Paul, Sven Schippling and Pablo Villoslada; 19. Future technological advances in optical coherence tomography Hiroshi Ishikawa and Joel Schuman; Index | |
| 520 | |a Optical coherence tomography (OCT) provides tissue morphology imagery at much higher resolution than other imaging modalities such as MRI or ultrasound, and the machines are comparatively cheaper. It is an easy technique to perform; is non-ionizing, and therefore safe. These benefits are driving a rapid transformation of OCT, from its principal application as a research tool, into an extension of the 'neurological examination' in routine office practice. Originally used in assessing the severity of tissue damage and prognosis of multiple sclerosis and various neuro-ophthalmic conditions, OCT is increasingly used in other neurological disorders such as Parkinson's disease, ALS, and Alzheimer's disease. This book is the first comprehensive review of the use of OCT in neurological diseases. The coverage includes a description of the technique and its utilization in a variety of neurologic conditions. Essential reading for neurologists, neuro-ophthalmologists, and neuroradiologists wanting an introductory account of the clinical applications of OCT. | ||
| 650 | 4 | |a Nervous system / Diseases / Diagnosis | |
| 650 | 4 | |a Central nervous system / Tomography | |
| 650 | 0 | 7 | |a Nervenkrankheit |0 (DE-588)1068493003 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Optische Kohärenztomografie |0 (DE-588)7727641-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Diagnose |0 (DE-588)4012040-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Optische Kohärenztomografie |0 (DE-588)7727641-3 |D s |
| 689 | 0 | 1 | |a Nervenkrankheit |0 (DE-588)1068493003 |D s |
| 689 | 0 | 2 | |a Diagnose |0 (DE-588)4012040-5 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Calabresi, Peter A. |d 1962- |0 (DE-588)1079827838 |4 edt | |
| 700 | 1 | |a Balcer, Laura J. |4 edt | |
| 700 | 1 | |a Frohman, Elliot M. |d 1959- |0 (DE-588)1079828532 |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-1-107-04130-1 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-1-107-68113-2 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/CBO9781139649506 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-20-CBO | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029349415 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1017/CBO9781139649506 |l BSB01 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1017/CBO9781139649506 |l FHN01 |p ZDB-20-CBO |q FHN_PDA_CBO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804176880974168064 |
|---|---|
| any_adam_object | |
| author2 | Calabresi, Peter A. 1962- Balcer, Laura J. Frohman, Elliot M. 1959- |
| author2_role | edt edt edt |
| author2_variant | p a c pa pac l j b lj ljb e m f em emf |
| author_GND | (DE-588)1079827838 (DE-588)1079828532 |
| author_facet | Calabresi, Peter A. 1962- Balcer, Laura J. Frohman, Elliot M. 1959- |
| building | Verbundindex |
| bvnumber | BV043940445 |
| collection | ZDB-20-CBO |
| contents | Machine generated contents note: Preface; 1. Introduction to optical coherence tomography in neurological diseases Peter A. Calabresi, Laura J. Balcer and Elliot M. Frohman; 2. Basic principles of optical coherence tomography Sven Schippling; 3. Anatomy of the anterior visual pathway Devin D. Mackay, Stephen L. Galetta and Sashank Prasad; 4. Optical coherence tomography in acute optic neuritis Andrew P.D. Henderson, S. Anand Trip and David H. Miller; 5. Optical coherence tomography and visual outcomes in acute optic neuritis Fiona Costello; 6. Optical coherence tomography and low contrast acuity Shin C. Beh and Laura J. Balcer; 7. Optical coherence tomography and electrophysiology of the visual pathway A. Klistorner, C.L. Fraser, C. Yiannikas and S.L. Graham; 8. Optical coherence tomography and electrophysiology of the optic nerve head Shin C. Beh, Zane Schnurman, Darrel Conger, Amy Conger, Benjamin M. Greenberg, Elliot M. Frohman and Teresa C. Frohman; 9. Meta-analysis of optical coherence tomography in multiple sclerosis Axel Petzold; 10. Optical coherence tomography and brain MRI in multiple sclerosis Shiv Saidha and Peter A. Calabresi; 11. Optical coherence tomography in neurodegenerative diseases Friedemann Paul and Alexander Ulrich Brandt; 12. Optical coherence tomography pathologies to know about in clinical practice Scott Newsome and John N. Ratchford; 13. Optical coherence tomography and retinal segmentation in neurological diseases Elias S. Sotirchos and Shiv Saidha; 14. Optical coherence tomography and retinal pathology in neurologic diseases Ari J. Green; 15. Retinal inflammation in MS revealed by optical coherence tomography and ophthalmoscopy Elena H. Martinez-Lapiscina, Bernardo Sanchez-Dalmau and Pablo Villoslada; 16. Optical coherence tomography and optic nerve MRI in demyelinating diseases Robert T. Naismith; 17. Optical coherence tomography in neurologic clinical trials Robert A. Bermel and Peter K. Kaiser; 18. Optical coherence tomography in multi-center setting: quality control issues Axel Petzold, Laura J. Balcer, Peter A. Calabresi, Fiona Costello, Elliot M. Frohman, Ari J. Green, Sasha Klistorner, Friedemann Paul, Sven Schippling and Pablo Villoslada; 19. Future technological advances in optical coherence tomography Hiroshi Ishikawa and Joel Schuman; Index |
| ctrlnum | (ZDB-20-CBO)CR9781139649506 (OCoLC)967678786 (DE-599)BVBBV043940445 |
| dewey-full | 616.8/04757 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.8/04757 |
| dewey-search | 616.8/04757 |
| dewey-sort | 3616.8 44757 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1017/CBO9781139649506 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06615nmm a2200589zc 4500</leader><controlfield tag="001">BV043940445</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20170505 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">161206s2015 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781139649506</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-139-64950-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/CBO9781139649506</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9781139649506</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)967678786</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043940445</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-92</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8/04757</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Optical coherence tomography in neurological diseases</subfield><subfield code="c">edited by Peter A. Calabresi, MD, FAAN, FANA, Professor of Neurology, Director of the Richard T. Johnson Division of Neuroimmulogy and Neuroinfectious Diseases, and Director of the Johns Hopkins Multiple Sclerosis Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA, Laura J. Balcer, MD, MSCE, FANA, Professor of Neurology, Population Health and Opthalmalogy, Vice Chair, Department of Neurology, NYU School of Medicine, NY, USA, Elliot M. Frohman, MD, PhD, FAAN, Professor of Neurology and Opthalmology, Distinguished Teaching Professor, Kenney-Marie Dixon Pickens, Distinguished Professor of MS Research, Irene Wadel & Robert Artha Distinguished Chair in Neurology, Director, Multiple Sclerosis and Neuroimmunology Program and Clinical Center for Multiple Sclerosis, University of Texas Southwestern School of Medicine</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (ix, 224 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from publisher's bibliographic system (viewed on 05 Oct 2015)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Machine generated contents note: Preface; 1. Introduction to optical coherence tomography in neurological diseases Peter A. Calabresi, Laura J. Balcer and Elliot M. Frohman; 2. Basic principles of optical coherence tomography Sven Schippling; 3. Anatomy of the anterior visual pathway Devin D. Mackay, Stephen L. Galetta and Sashank Prasad; 4. Optical coherence tomography in acute optic neuritis Andrew P.D. Henderson, S. Anand Trip and David H. Miller; 5. Optical coherence tomography and visual outcomes in acute optic neuritis Fiona Costello; 6. Optical coherence tomography and low contrast acuity Shin C. Beh and Laura J. Balcer; 7. Optical coherence tomography and electrophysiology of the visual pathway A. Klistorner, C.L. Fraser, C. Yiannikas and S.L. Graham; 8. Optical coherence tomography and electrophysiology of the optic nerve head Shin C. Beh, Zane Schnurman, Darrel Conger, Amy Conger, Benjamin M. Greenberg, Elliot M. Frohman and Teresa C. Frohman; 9. </subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Meta-analysis of optical coherence tomography in multiple sclerosis Axel Petzold; 10. Optical coherence tomography and brain MRI in multiple sclerosis Shiv Saidha and Peter A. Calabresi; 11. Optical coherence tomography in neurodegenerative diseases Friedemann Paul and Alexander Ulrich Brandt; 12. Optical coherence tomography pathologies to know about in clinical practice Scott Newsome and John N. Ratchford; 13. Optical coherence tomography and retinal segmentation in neurological diseases Elias S. Sotirchos and Shiv Saidha; 14. Optical coherence tomography and retinal pathology in neurologic diseases Ari J. Green; 15. Retinal inflammation in MS revealed by optical coherence tomography and ophthalmoscopy Elena H. Martinez-Lapiscina, Bernardo Sanchez-Dalmau and Pablo Villoslada; 16. Optical coherence tomography and optic nerve MRI in demyelinating diseases Robert T. Naismith; 17. Optical coherence tomography in neurologic clinical trials Robert A. Bermel and Peter K. Kaiser; 18. </subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Optical coherence tomography in multi-center setting: quality control issues Axel Petzold, Laura J. Balcer, Peter A. Calabresi, Fiona Costello, Elliot M. Frohman, Ari J. Green, Sasha Klistorner, Friedemann Paul, Sven Schippling and Pablo Villoslada; 19. Future technological advances in optical coherence tomography Hiroshi Ishikawa and Joel Schuman; Index</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Optical coherence tomography (OCT) provides tissue morphology imagery at much higher resolution than other imaging modalities such as MRI or ultrasound, and the machines are comparatively cheaper. It is an easy technique to perform; is non-ionizing, and therefore safe. These benefits are driving a rapid transformation of OCT, from its principal application as a research tool, into an extension of the 'neurological examination' in routine office practice. Originally used in assessing the severity of tissue damage and prognosis of multiple sclerosis and various neuro-ophthalmic conditions, OCT is increasingly used in other neurological disorders such as Parkinson's disease, ALS, and Alzheimer's disease. This book is the first comprehensive review of the use of OCT in neurological diseases. The coverage includes a description of the technique and its utilization in a variety of neurologic conditions. Essential reading for neurologists, neuro-ophthalmologists, and neuroradiologists wanting an introductory account of the clinical applications of OCT.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nervous system / Diseases / Diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Central nervous system / Tomography</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nervenkrankheit</subfield><subfield code="0">(DE-588)1068493003</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Optische Kohärenztomografie</subfield><subfield code="0">(DE-588)7727641-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Diagnose</subfield><subfield code="0">(DE-588)4012040-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Optische Kohärenztomografie</subfield><subfield code="0">(DE-588)7727641-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Nervenkrankheit</subfield><subfield code="0">(DE-588)1068493003</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Diagnose</subfield><subfield code="0">(DE-588)4012040-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calabresi, Peter A.</subfield><subfield code="d">1962-</subfield><subfield code="0">(DE-588)1079827838</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Balcer, Laura J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Frohman, Elliot M.</subfield><subfield code="d">1959-</subfield><subfield code="0">(DE-588)1079828532</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-1-107-04130-1</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-1-107-68113-2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/CBO9781139649506</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029349415</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9781139649506</subfield><subfield code="l">BSB01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9781139649506</subfield><subfield code="l">FHN01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">FHN_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV043940445 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:39:13Z |
| institution | BVB |
| isbn | 9781139649506 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029349415 |
| oclc_num | 967678786 |
| open_access_boolean | |
| owner | DE-12 DE-92 |
| owner_facet | DE-12 DE-92 |
| physical | 1 online resource (ix, 224 pages) |
| psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO FHN_PDA_CBO |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Optical coherence tomography in neurological diseases edited by Peter A. Calabresi, MD, FAAN, FANA, Professor of Neurology, Director of the Richard T. Johnson Division of Neuroimmulogy and Neuroinfectious Diseases, and Director of the Johns Hopkins Multiple Sclerosis Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA, Laura J. Balcer, MD, MSCE, FANA, Professor of Neurology, Population Health and Opthalmalogy, Vice Chair, Department of Neurology, NYU School of Medicine, NY, USA, Elliot M. Frohman, MD, PhD, FAAN, Professor of Neurology and Opthalmology, Distinguished Teaching Professor, Kenney-Marie Dixon Pickens, Distinguished Professor of MS Research, Irene Wadel & Robert Artha Distinguished Chair in Neurology, Director, Multiple Sclerosis and Neuroimmunology Program and Clinical Center for Multiple Sclerosis, University of Texas Southwestern School of Medicine Cambridge Cambridge University Press 2015 1 online resource (ix, 224 pages) txt rdacontent c rdamedia cr rdacarrier Title from publisher's bibliographic system (viewed on 05 Oct 2015) Machine generated contents note: Preface; 1. Introduction to optical coherence tomography in neurological diseases Peter A. Calabresi, Laura J. Balcer and Elliot M. Frohman; 2. Basic principles of optical coherence tomography Sven Schippling; 3. Anatomy of the anterior visual pathway Devin D. Mackay, Stephen L. Galetta and Sashank Prasad; 4. Optical coherence tomography in acute optic neuritis Andrew P.D. Henderson, S. Anand Trip and David H. Miller; 5. Optical coherence tomography and visual outcomes in acute optic neuritis Fiona Costello; 6. Optical coherence tomography and low contrast acuity Shin C. Beh and Laura J. Balcer; 7. Optical coherence tomography and electrophysiology of the visual pathway A. Klistorner, C.L. Fraser, C. Yiannikas and S.L. Graham; 8. Optical coherence tomography and electrophysiology of the optic nerve head Shin C. Beh, Zane Schnurman, Darrel Conger, Amy Conger, Benjamin M. Greenberg, Elliot M. Frohman and Teresa C. Frohman; 9. Meta-analysis of optical coherence tomography in multiple sclerosis Axel Petzold; 10. Optical coherence tomography and brain MRI in multiple sclerosis Shiv Saidha and Peter A. Calabresi; 11. Optical coherence tomography in neurodegenerative diseases Friedemann Paul and Alexander Ulrich Brandt; 12. Optical coherence tomography pathologies to know about in clinical practice Scott Newsome and John N. Ratchford; 13. Optical coherence tomography and retinal segmentation in neurological diseases Elias S. Sotirchos and Shiv Saidha; 14. Optical coherence tomography and retinal pathology in neurologic diseases Ari J. Green; 15. Retinal inflammation in MS revealed by optical coherence tomography and ophthalmoscopy Elena H. Martinez-Lapiscina, Bernardo Sanchez-Dalmau and Pablo Villoslada; 16. Optical coherence tomography and optic nerve MRI in demyelinating diseases Robert T. Naismith; 17. Optical coherence tomography in neurologic clinical trials Robert A. Bermel and Peter K. Kaiser; 18. Optical coherence tomography in multi-center setting: quality control issues Axel Petzold, Laura J. Balcer, Peter A. Calabresi, Fiona Costello, Elliot M. Frohman, Ari J. Green, Sasha Klistorner, Friedemann Paul, Sven Schippling and Pablo Villoslada; 19. Future technological advances in optical coherence tomography Hiroshi Ishikawa and Joel Schuman; Index Optical coherence tomography (OCT) provides tissue morphology imagery at much higher resolution than other imaging modalities such as MRI or ultrasound, and the machines are comparatively cheaper. It is an easy technique to perform; is non-ionizing, and therefore safe. These benefits are driving a rapid transformation of OCT, from its principal application as a research tool, into an extension of the 'neurological examination' in routine office practice. Originally used in assessing the severity of tissue damage and prognosis of multiple sclerosis and various neuro-ophthalmic conditions, OCT is increasingly used in other neurological disorders such as Parkinson's disease, ALS, and Alzheimer's disease. This book is the first comprehensive review of the use of OCT in neurological diseases. The coverage includes a description of the technique and its utilization in a variety of neurologic conditions. Essential reading for neurologists, neuro-ophthalmologists, and neuroradiologists wanting an introductory account of the clinical applications of OCT. Nervous system / Diseases / Diagnosis Central nervous system / Tomography Nervenkrankheit (DE-588)1068493003 gnd rswk-swf Optische Kohärenztomografie (DE-588)7727641-3 gnd rswk-swf Diagnose (DE-588)4012040-5 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Optische Kohärenztomografie (DE-588)7727641-3 s Nervenkrankheit (DE-588)1068493003 s Diagnose (DE-588)4012040-5 s 2\p DE-604 Calabresi, Peter A. 1962- (DE-588)1079827838 edt Balcer, Laura J. edt Frohman, Elliot M. 1959- (DE-588)1079828532 edt Erscheint auch als Druckausgabe 978-1-107-04130-1 Erscheint auch als Druckausgabe 978-1-107-68113-2 https://doi.org/10.1017/CBO9781139649506 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Optical coherence tomography in neurological diseases Machine generated contents note: Preface; 1. Introduction to optical coherence tomography in neurological diseases Peter A. Calabresi, Laura J. Balcer and Elliot M. Frohman; 2. Basic principles of optical coherence tomography Sven Schippling; 3. Anatomy of the anterior visual pathway Devin D. Mackay, Stephen L. Galetta and Sashank Prasad; 4. Optical coherence tomography in acute optic neuritis Andrew P.D. Henderson, S. Anand Trip and David H. Miller; 5. Optical coherence tomography and visual outcomes in acute optic neuritis Fiona Costello; 6. Optical coherence tomography and low contrast acuity Shin C. Beh and Laura J. Balcer; 7. Optical coherence tomography and electrophysiology of the visual pathway A. Klistorner, C.L. Fraser, C. Yiannikas and S.L. Graham; 8. Optical coherence tomography and electrophysiology of the optic nerve head Shin C. Beh, Zane Schnurman, Darrel Conger, Amy Conger, Benjamin M. Greenberg, Elliot M. Frohman and Teresa C. Frohman; 9. Meta-analysis of optical coherence tomography in multiple sclerosis Axel Petzold; 10. Optical coherence tomography and brain MRI in multiple sclerosis Shiv Saidha and Peter A. Calabresi; 11. Optical coherence tomography in neurodegenerative diseases Friedemann Paul and Alexander Ulrich Brandt; 12. Optical coherence tomography pathologies to know about in clinical practice Scott Newsome and John N. Ratchford; 13. Optical coherence tomography and retinal segmentation in neurological diseases Elias S. Sotirchos and Shiv Saidha; 14. Optical coherence tomography and retinal pathology in neurologic diseases Ari J. Green; 15. Retinal inflammation in MS revealed by optical coherence tomography and ophthalmoscopy Elena H. Martinez-Lapiscina, Bernardo Sanchez-Dalmau and Pablo Villoslada; 16. Optical coherence tomography and optic nerve MRI in demyelinating diseases Robert T. Naismith; 17. Optical coherence tomography in neurologic clinical trials Robert A. Bermel and Peter K. Kaiser; 18. Optical coherence tomography in multi-center setting: quality control issues Axel Petzold, Laura J. Balcer, Peter A. Calabresi, Fiona Costello, Elliot M. Frohman, Ari J. Green, Sasha Klistorner, Friedemann Paul, Sven Schippling and Pablo Villoslada; 19. Future technological advances in optical coherence tomography Hiroshi Ishikawa and Joel Schuman; Index Nervous system / Diseases / Diagnosis Central nervous system / Tomography Nervenkrankheit (DE-588)1068493003 gnd Optische Kohärenztomografie (DE-588)7727641-3 gnd Diagnose (DE-588)4012040-5 gnd |
| subject_GND | (DE-588)1068493003 (DE-588)7727641-3 (DE-588)4012040-5 (DE-588)4143413-4 |
| title | Optical coherence tomography in neurological diseases |
| title_auth | Optical coherence tomography in neurological diseases |
| title_exact_search | Optical coherence tomography in neurological diseases |
| title_full | Optical coherence tomography in neurological diseases edited by Peter A. Calabresi, MD, FAAN, FANA, Professor of Neurology, Director of the Richard T. Johnson Division of Neuroimmulogy and Neuroinfectious Diseases, and Director of the Johns Hopkins Multiple Sclerosis Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA, Laura J. Balcer, MD, MSCE, FANA, Professor of Neurology, Population Health and Opthalmalogy, Vice Chair, Department of Neurology, NYU School of Medicine, NY, USA, Elliot M. Frohman, MD, PhD, FAAN, Professor of Neurology and Opthalmology, Distinguished Teaching Professor, Kenney-Marie Dixon Pickens, Distinguished Professor of MS Research, Irene Wadel & Robert Artha Distinguished Chair in Neurology, Director, Multiple Sclerosis and Neuroimmunology Program and Clinical Center for Multiple Sclerosis, University of Texas Southwestern School of Medicine |
| title_fullStr | Optical coherence tomography in neurological diseases edited by Peter A. Calabresi, MD, FAAN, FANA, Professor of Neurology, Director of the Richard T. Johnson Division of Neuroimmulogy and Neuroinfectious Diseases, and Director of the Johns Hopkins Multiple Sclerosis Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA, Laura J. Balcer, MD, MSCE, FANA, Professor of Neurology, Population Health and Opthalmalogy, Vice Chair, Department of Neurology, NYU School of Medicine, NY, USA, Elliot M. Frohman, MD, PhD, FAAN, Professor of Neurology and Opthalmology, Distinguished Teaching Professor, Kenney-Marie Dixon Pickens, Distinguished Professor of MS Research, Irene Wadel & Robert Artha Distinguished Chair in Neurology, Director, Multiple Sclerosis and Neuroimmunology Program and Clinical Center for Multiple Sclerosis, University of Texas Southwestern School of Medicine |
| title_full_unstemmed | Optical coherence tomography in neurological diseases edited by Peter A. Calabresi, MD, FAAN, FANA, Professor of Neurology, Director of the Richard T. Johnson Division of Neuroimmulogy and Neuroinfectious Diseases, and Director of the Johns Hopkins Multiple Sclerosis Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA, Laura J. Balcer, MD, MSCE, FANA, Professor of Neurology, Population Health and Opthalmalogy, Vice Chair, Department of Neurology, NYU School of Medicine, NY, USA, Elliot M. Frohman, MD, PhD, FAAN, Professor of Neurology and Opthalmology, Distinguished Teaching Professor, Kenney-Marie Dixon Pickens, Distinguished Professor of MS Research, Irene Wadel & Robert Artha Distinguished Chair in Neurology, Director, Multiple Sclerosis and Neuroimmunology Program and Clinical Center for Multiple Sclerosis, University of Texas Southwestern School of Medicine |
| title_short | Optical coherence tomography in neurological diseases |
| title_sort | optical coherence tomography in neurological diseases |
| topic | Nervous system / Diseases / Diagnosis Central nervous system / Tomography Nervenkrankheit (DE-588)1068493003 gnd Optische Kohärenztomografie (DE-588)7727641-3 gnd Diagnose (DE-588)4012040-5 gnd |
| topic_facet | Nervous system / Diseases / Diagnosis Central nervous system / Tomography Nervenkrankheit Optische Kohärenztomografie Diagnose Aufsatzsammlung |
| url | https://doi.org/10.1017/CBO9781139649506 |
| work_keys_str_mv | AT calabresipetera opticalcoherencetomographyinneurologicaldiseases AT balcerlauraj opticalcoherencetomographyinneurologicaldiseases AT frohmanelliotm opticalcoherencetomographyinneurologicaldiseases |